CLB Core Laboratories N V

Price (delayed)

$33.75

Market cap

$1.5B

P/E Ratio

N/A

Dividend/share

$0.28

EPS

-$2.27

Enterprise value

$1.82B

Sector: Energy
Industry: Oil & Gas Equipment & Services

Highlights

CLB's debt is down by 11% YoY and by 6% from the previous quarter
CLB's equity has plunged by 64% YoY but it is up by 9% from the previous quarter
Core Laboratories N V's EPS has plunged by 200% YoY and by 26% from the previous quarter
The quick ratio has shrunk by 54% YoY and by 53% QoQ

Key stats

What are the main financial stats of CLB
Market
Shares outstanding
44.49M
Market cap
$1.5B
Enterprise value
$1.82B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
22.2
Price to sales (P/S)
2.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.43
Earnings
Revenue
$530.3M
EBIT
-$79.27M
EBITDA
-$57.71M
Free cash flow
$78.18M
Per share
EPS
-$2.27
Free cash flow per share
$1.76
Book value per share
$1.52
Revenue per share
$11.92
TBVPS
$10.85
Balance sheet
Total assets
$590.81M
Total liabilities
$519.11M
Debt
$333.02M
Equity
$67.63M
Working capital
-$2.25M
Liquidity
Debt to equity
4.92
Current ratio
0.99
Quick ratio
0.58
Net debt/EBITDA
-5.51
Margins
EBITDA margin
-10.9%
Gross margin
23.7%
Net margin
-19%
Operating margin
-14.9%
Efficiency
Return on assets
-15.4%
Return on equity
-108.1%
Return on invested capital
-10.7%
Return on capital employed
-18.9%
Return on sales
-14.9%
Dividend
Dividend yield
0.83%
DPS
$0.28
Payout ratio
N/A

CLB stock price

How has the Core Laboratories N V stock price performed over time
Intraday
-4.82%
1 week
8.94%
1 month
17.6%
1 year
-15.35%
YTD
27.31%
QTD
27.31%

Financial performance

How have Core Laboratories N V's revenue and profit performed over time
Revenue
$530.3M
Gross profit
$125.7M
Operating income
-$79.15M
Net income
-$100.84M
Gross margin
23.7%
Net margin
-19%
Core Laboratories N V's operating income has shrunk by 185% YoY and by 34% QoQ
The operating margin has plunged by 51% from the previous quarter
CLB's net margin is down by 42% from the previous quarter
CLB's gross profit is down by 31% year-on-year and by 15% since the previous quarter

Growth

What is Core Laboratories N V's growth rate over time

Valuation

What is Core Laboratories N V stock price valuation
P/E
N/A
P/B
22.2
P/S
2.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.43
Core Laboratories N V's EPS has plunged by 200% YoY and by 26% from the previous quarter
The P/B is 118% above the last 4 quarters average of 10.2 but 6% below the 5-year quarterly average of 23.6
CLB's equity has plunged by 64% YoY but it is up by 9% from the previous quarter
CLB's price to sales (P/S) is 89% higher than its last 4 quarters average of 1.5 but 49% lower than its 5-year quarterly average of 5.5
The company's revenue fell by 23% YoY and by 11% QoQ

Efficiency

How efficient is Core Laboratories N V business performance
The return on invested capital has dropped by 178% year-on-year and by 41% since the previous quarter
The return on equity has dropped by 67% since the previous quarter
Core Laboratories N V's ROS has decreased by 49% from the previous quarter
The ROA has contracted by 36% from the previous quarter

Dividends

What is CLB's dividend history
DPS
$0.28
Dividend yield
0.83%
Payout ratio
N/A
Recent dividends

Financial health

How did Core Laboratories N V financials performed over time
The total assets is 14% greater than the total liabilities
The quick ratio has shrunk by 54% YoY and by 53% QoQ
CLB's current ratio is down by 49% since the previous quarter and by 48% year-on-year
The debt to equity has soared by 151% YoY but it has decreased by 14% QoQ
CLB's equity has plunged by 64% YoY but it is up by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.